Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 250 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2022-02-10 | 2022-05-19 | 154723 |
| TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2022-02-10 | 2022-05-19 | 154726 |
| TEVA-PRAZOSIN | 5MG | TABLET | Resolved | 2022-02-10 | 2022-03-24 | 154729 |
| TEVA-AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-02-17 | 2022-04-21 | 155134 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-02-17 | 2022-03-24 | 155137 |
| TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-02-17 | 2023-02-09 | 155140 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2022-02-17 | 2022-04-21 | 155149 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2022-02-17 | 2022-03-24 | 155152 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2022-02-17 | 2022-03-24 | 155155 |
| TEVA-FLUOXETINE | 10MG | CAPSULE | Resolved | 2022-02-17 | 2022-02-17 | 155162 |
| TEVA-FLUOXETINE | 20MG | CAPSULE | Resolved | 2022-02-17 | 2024-05-09 | 155171 |
| TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2022-02-17 | 2022-04-21 | 155174 |
| TEVA-KETOCONAZOLE | 200MG | TABLET | Resolved | 2022-02-17 | 2022-05-26 | 155177 |
| TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2022-02-17 | 2022-04-21 | 155180 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2022-02-17 | 2022-03-24 | 155183 |
| TEVA-TENOFOVIR | 300MG | TABLET | Resolved | 2022-02-17 | 2022-12-15 | 155186 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2022-02-24 | 2022-03-09 | 155554 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-02-24 | 2022-04-01 | 155557 |
| TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2022-02-24 | 2022-04-09 | 155560 |
| TEVA-AMPHETAMINE XR | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-02-24 | 2022-04-21 | 155563 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64609 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |